213 related articles for article (PubMed ID: 12076626)
1. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
Wei S; Marches F; Daniel B; Sonda S; Heidenreich K; Curiel T
Int J Parasitol; 2002 Jul; 32(8):969-77. PubMed ID: 12076626
[TBL] [Abstract][Full Text] [Related]
2. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.
Wei S; Daniel BJ; Brumlik MJ; Burow ME; Zou W; Khan IA; Wadsworth S; Siekierka J; Curiel TJ
Antimicrob Agents Chemother; 2007 Dec; 51(12):4324-8. PubMed ID: 17923491
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii.
Brumlik MJ; Wei S; Finstad K; Nesbit J; Hyman LE; Lacey M; Burow ME; Curiel TJ
Int J Parasitol; 2004 Oct; 34(11):1245-54. PubMed ID: 15491587
[TBL] [Abstract][Full Text] [Related]
4. Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
Brumlik MJ; Nkhoma S; Kious MJ; Thompson GR; Patterson TF; Siekierka JJ; Anderson TJ; Curiel TJ
Exp Parasitol; 2011 Jun; 128(2):170-5. PubMed ID: 21338604
[TBL] [Abstract][Full Text] [Related]
5. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase.
Kumar S; Jiang MS; Adams JL; Lee JC
Biochem Biophys Res Commun; 1999 Oct; 263(3):825-31. PubMed ID: 10512765
[TBL] [Abstract][Full Text] [Related]
6. Activation of the cellular mitogen-activated protein kinase pathways ERK, P38 and JNK during Toxoplasma gondii invasion.
Valère A; Garnotel R; Villena I; Guenounou M; Pinon JM; Aubert D
Parasite; 2003 Mar; 10(1):59-64. PubMed ID: 12669350
[TBL] [Abstract][Full Text] [Related]
7. Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus.
Hirasawa K; Kim A; Han HS; Han J; Jun HS; Yoon JW
J Virol; 2003 May; 77(10):5649-56. PubMed ID: 12719557
[TBL] [Abstract][Full Text] [Related]
8. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding.
Frantz B; Klatt T; Pang M; Parsons J; Rolando A; Williams H; Tocci MJ; O'Keefe SJ; O'Neill EA
Biochemistry; 1998 Sep; 37(39):13846-53. PubMed ID: 9753474
[TBL] [Abstract][Full Text] [Related]
9. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
Kayali AG; Austin DA; Webster NJ
Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
[TBL] [Abstract][Full Text] [Related]
11. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy.
Purves T; Middlemas A; Agthong S; Jude EB; Boulton AJ; Fernyhough P; Tomlinson DR
FASEB J; 2001 Nov; 15(13):2508-14. PubMed ID: 11689477
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Networks of the PI3K/AKT and MAPK Pathways for Regulating Toxoplasma gondii-Induced IL-23 and IL-12 Production in Human THP-1 Cells.
Quan JH; Chu JQ; Kwon J; Choi IW; Ismail HA; Zhou W; Cha GH; Zhou Y; Yuk JM; Jo EK; Lee YH
PLoS One; 2015; 10(11):e0141550. PubMed ID: 26528819
[TBL] [Abstract][Full Text] [Related]
13. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
14. Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases.
Reimer RA
J Endocrinol; 2006 Oct; 191(1):159-70. PubMed ID: 17065399
[TBL] [Abstract][Full Text] [Related]
15. Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in alpha1B-adrenergic receptor/Galphaq-induced inhibition of cell proliferation.
Yamauchi J; Itoh H; Shinoura H; Miyamoto Y; Hirasawa A; Kaziro Y; Tsujimoto G
Biochem Biophys Res Commun; 2001 Mar; 281(4):1019-23. PubMed ID: 11237765
[TBL] [Abstract][Full Text] [Related]
16. P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production.
Lahti A; Kankaanranta H; Moilanen E
Eur J Pharmacol; 2002 Nov; 454(2-3):115-23. PubMed ID: 12421638
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors.
Flamigni F; Facchini A; Giordano E; Tantini B; Stefanelli C
Biochem Pharmacol; 2001 Jan; 61(1):25-32. PubMed ID: 11137705
[TBL] [Abstract][Full Text] [Related]
18. Differential contribution of spinal mitogen-activated protein kinases to the phase of long-lasting allodynia evoked by intrathecal administration of ATP in rats.
Nakagawa T; Wakamatsu K; Maeda S; Shirakawa H; Kaneko S
Biol Pharm Bull; 2008 Jun; 31(6):1164-8. PubMed ID: 18520049
[TBL] [Abstract][Full Text] [Related]
19. Oral malodorous compound inhibits osteoblast proliferation.
Imai T; Ii H; Yaegaki K; Murata T; Sato T; Kamoda T
J Periodontol; 2009 Dec; 80(12):2028-34. PubMed ID: 19961386
[TBL] [Abstract][Full Text] [Related]
20. Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells.
Kimata M; Inagaki N; Kato T; Miura T; Serizawa I; Nagai H
Biochem Pharmacol; 2000 Aug; 60(4):589-94. PubMed ID: 10874134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
